Patents by Inventor Jeffrey Crabb

Jeffrey Crabb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chemical process 632
    Patent number: 8076481
    Abstract: A process for preparing pharmaceutically active compounds of formula (I) or a salt thereof wherein R1, n, m, R3, R6, X1, X2, X3 and X4 are as defined in the specification, is described. Novel intermediates are also described and claimed.
    Type: Grant
    Filed: February 15, 2010
    Date of Patent: December 13, 2011
    Assignee: AstraZeneca AB
    Inventors: Michael Butters, Jeffrey Crabb, Philip Hopes, Bharti Patel
  • CHEMICAL PROCESS 632
    Publication number: 20100210841
    Abstract: A process for preparing pharmaceutically active compounds of formula (I) or a salt thereof wherein R1, n, m, R3, R6, X1, X2, X3 and X4 are as defined in the specification, is described. Novel intermediates are also described and claimed.
    Type: Application
    Filed: February 15, 2010
    Publication date: August 19, 2010
    Applicant: AstraZeneca AB
    Inventors: Michael Butters, Jeffrey Crabb, Philip Hopes, Bharti Patel
  • Crystalline form of bis [(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl] (3r,5s)-3, 5-dihydroxyhept-6-enoicacid] calcium salt
    Publication number: 20060293355
    Abstract: Two polymorphic forms of bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid]calcium salt, processes for making them and their use as HMG Co-A reductase inhibitors are described.
    Type: Application
    Filed: September 8, 2004
    Publication date: December 28, 2006
    Inventors: Rebecca Booth, Peter Cittern, Jeffrey Crabb, John Horbury, David Jones